Cargando…

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options

Epilepsy is a chronic neurologic disorder that affects over 70 million people worldwide. Despite the availability of over 20 antiseizure drugs (ASDs) for symptomatic treatment of epileptic seizures, about one-third of patients with epilepsy have seizures refractory to pharmacotherapy. Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Löscher, Wolfgang, Potschka, Heidrun, Sisodiya, Sanjay M., Vezzani, Annamaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Pharmacology and Experimental Therapeutics 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300324/ https://www.ncbi.nlm.nih.gov/pubmed/32540959 http://dx.doi.org/10.1124/pr.120.019539

Ejemplares similares

Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments
por: Löscher, Wolfgang, et al.
Publicado: (2023)

Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications
por: Jain, Shreshta, et al.
Publicado: (2021)

An in vitro model of drug-resistant seizures for selecting clinically effective antiseizure medications in Febrile Infection-Related Epilepsy Syndrome
por: Cerovic, Milica, et al.
Publicado: (2023)

A spatiotemporal study of gliosis in relation to depth electrode tracks in drug-resistant epilepsy
por: Goc, Joanna, et al.
Publicado: (2014)

Cyclooxygenase-2 Inhibition as an Add-On Strategy in Drug Resistant Epilepsy—A Canine Translational Study
por: Fischer, Andrea, et al.
Publicado: (2022)

Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects
por: Nowakowska, Marta, et al.
Publicado: (2022)

Antiepileptic Drug Withdrawal in Dogs with Epilepsy
por: Gesell, Felix Kaspar, et al.
Publicado: (2015)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection
por: Löscher, Wolfgang, et al.
Publicado: (2022)

Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
por: Löscher, Wolfgang
Publicado: (2021)

International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy
por: Potschka, Heidrun, et al.
Publicado: (2015)

Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
por: Kriechbaumer, Sandra R. P., et al.
Publicado: (2022)

Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies
por: Ravizza, Teresa, et al.
Publicado: (2018)

Molecular alterations of the TLR4-signaling cascade in canine epilepsy
por: von Rüden, Eva-Lotta, et al.
Publicado: (2020)

Novel Intrinsic Mechanisms of Active Drug Extrusion at the Blood-Brain Barrier: Potential Targets for Enhancing Drug Delivery to the Brain?
por: Löscher, Wolfgang, et al.
Publicado: (2020)

International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in Europe
por: Bhatti, Sofie F.M., et al.
Publicado: (2015)

Dogs as a Natural Animal Model of Epilepsy
por: Löscher, Wolfgang
Publicado: (2022)

Editorial: Experimental Models of Epilepsy and Related Comorbidities
por: Chakraborti, Ayanabha, et al.
Publicado: (2019)

Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2016)

Array comparative genomic hybridization: Results from an adult population with drug-resistant epilepsy and co-morbidities
por: Galizia, Elizabeth C., et al.
Publicado: (2012)

Editorial: Complex Scenarios of Drug-Resistant Epilepsies: Diagnostic Challenges and Novel Therapeutic Options
por: Didato, Giuseppe, et al.
Publicado: (2022)

Anticholinergics: A potential option for preventing posttraumatic epilepsy
por: Sanabria, Viviam, et al.
Publicado: (2023)

In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery
por: Di Sapia, Rossella, et al.
Publicado: (2021)

Climate change and epilepsy: Insights from clinical and basic science studies
por: Gulcebi, Medine I., et al.
Publicado: (2021)

Risk factors and outcome of hyperammonaemia in people with epilepsy
por: Vakrinou, Angeliki, et al.
Publicado: (2022)

Structural, Molecular, and Functional Alterations of the Blood-Brain Barrier during Epileptogenesis and Epilepsy: A Cause, Consequence, or Both?
por: Löscher, Wolfgang, et al.
Publicado: (2020)

Brain Inflammation and Seizures: Evolving Concepts and New Findings in the Last 2 Decades
por: Vezzani, Annamaria
Publicado: (2020)

Regional thalamic neuropathology in patients with hippocampal sclerosis and epilepsy: A postmortem study
por: Sinjab, Barah, et al.
Publicado: (2013)

Potential surgical therapies for drug‐resistant focal epilepsy
por: Shan, Wei, et al.
Publicado: (2021)

Montelukast: The New Therapeutic Option for the Treatment of Epilepsy
por: Tesfaye, Bekalu Amare, et al.
Publicado: (2021)

Epilepsy drugs and effects on fetal development: Potential mechanisms
por: Etemad, Leila, et al.
Publicado: (2012)

Genome‐wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug‐resistant epilepsy
por: Schoeler, Natasha E., et al.
Publicado: (2018)

Novel subscalp and intracranial devices to wirelessly record and analyze continuous EEG in unsedated, behaving dogs in their natural environments: A new paradigm in canine epilepsy research
por: Löscher, Wolfgang, et al.
Publicado: (2022)

Rare and Complex Epilepsies from Childhood to Adulthood: Requirements for Separate Management or Scope for a Lifespan Holistic Approach?
por: Balestrini, Simona, et al.
Publicado: (2021)

The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy
por: Pang, Serena, et al.
Publicado: (2022)

Use of Innovative SPECT Techniques in the Presurgical Evaluation of Patients with Nonlesional Extratemporal Drug-Resistant Epilepsy
por: Yassin, Ahmed, et al.
Publicado: (2021)

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs
por: Svob Strac, Dubravka, et al.
Publicado: (2016)

Valproate Use Is Associated With Posterior Cortical Thinning and Ventricular Enlargement in Epilepsy Patients
por: Tondelli, Manuela, et al.
Publicado: (2020)

Transcranial magnetic stimulation as a tool to understand genetic conditions associated with epilepsy
por: Silvennoinen, Katri, et al.
Publicado: (2020)

Neuropathology of 16p13.11 Deletion in Epilepsy
por: Liu, Joan Y. W., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1lqjd9qnjjtkd8hijgq3vhmidh